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Background: In the latest decades, epidemiological studies on allergic disorders in children, including atopic
dermatitis, rhinitis and asthma, demonstrated a continuous increase in prevalence. However, such studies are
usually performed by questionnaires and, sometimes, by skin prick test or in vitro IgE tests, while the portion of
allergy sustained by the cell-mediated mechanism is neglected, because the essential test, i.e. the atopy patch test
is not performed.
Methods: This cross-sectional survey studied by a specific questionnaire, skin prick test and atopy patch test, an
unselected population, represented by the entire scholastic population attending a Primary school and a Junior
Secondary school in the rural town of San Marco in Lamis, 12.000 inhabitants (Puglia, Italy).
Results: Among the 456 subjects included, 78 (17.1 %) had a positive skin prick test and 57 (12.5 %) had a positive
atopy patch test. In particular, 13.4 % of subjects were positive only to skin prick test and 8.8 % were positive only
to atopy patch test. The allergen most frequently positive was the house dust mite, with 41 positive results to skin
prick test and 55 to atopy patch test, while for pollen positive results concerned almost exclusively the skin prick
test.
Conclusions: This survey on an unselected population of children detected a prevalence of positive results to
atopy patch test not so distant from the positive results to skin prick test, and in 8.8 % of subjects the atopy patch
test was the only positive test. This would suggest to add the atopy patch test in future epidemiological studies on
allergy, in order to avoid to overlook the not negligible portion of patients with
T-cell-mediated allergy.
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The atopy patch test (APT) was introduced in the 1980s
using the technique of the patch test, used for diagnosis
of contact dermatitis, to test the T-cell mediated
sensitization to food allergens and inhalant allergens in
patients with atopic dermatitis (AD) [1]. Recent research
has shown that also in patients with respiratory diseases
such as rhinitis and asthma the allergic symptoms may
be sustained by T-cell mediated reactions as demon-
strated by positive results to APT. Importantly, in pa-
tients with T-cell-mediated allergy the APT can be the
only positive test [2-5]. These clinical data on the role of
the APT are supported by evidence on the capacity of* Correspondence: cristoforo.incorvaia@gmail.com
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unless otherwise stated.such test to reproduce the pathophysiologic events of
AD. In particular, the application of the APT to skin of
AD patients is followed by an influx of inflammatory
dendritic epidermal cells [6], being possible to detect,
24 hours after APT, a Th2 cytokine pattern, with a shift
to a Th1 pattern, as occurs in chronic AD skin lesions,
after 48 hours [7,8].
These capacities should suggest that the APT would
be useful in epidemiologic studies on allergic diseases.
Indeed, the prevalence of positive APT was evaluated
only in studies on allergic subjects. In particular, a multi-
centric European survey on patients with AD found that
APT to food and inhalant allergens was frequently posi-
tive, ranging from a maximum value of 39 % for house
dust mites (HDM) to a minimum of 9 % for celery; of
note, positive APT with negative skin prick test (SPT) orThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in 17 % of the patients [9]. A very recent study per-
formed the APT in children with eosinophilic esopha-
gitis, with positive results in around 46 % of cases [10].
Instead, epidemiologic surveys on allergy in the gen-
eral population commonly use questionnaires for symp-
toms, SPT and specific IgE measurement [11-13], but no
study employing the APT is thus far available. We evalu-
ated the prevalence of positive APT and SPT in an unse-
lected population of subjects in pediatric age.Methods
Patients
This cross-sectional study included the entire scholastic
population attending a Primary school and a Junior Sec-
ondary school in a rural town in Southern Italy (San
Marco in Lamis, 12.000 inhabitants, Puglia). During the
2009–2010 school year we recruited 459 pupils and stu-
dents [246 males (53.6 %), 213 females (46.4 %), age
range 7.3-13.9 years, mean age 10.8 ± 1.5 years; median
age 11.0 years]
The study was approved by written informed consent
from the Headmaster of the School and also from all the
recruited subject’s parents.Table 1 Allergens used for APT
Position Allergen gr ± 10 %
1 Alternaria 0,085
2 Cat epithelium 0,086
3 Grass pollen 0,084
4 House dust mites (Dermatophagoides) 0,085
5 Compositae pollen 0,086
6 Cypress pollen 0,088
7 Parietaria pollen 0,088
8 Petrolatum control 0,085Methods
We gave each and every one of the pupil’s parents a
written questionnaire (WQ), consisting of 4 pages. This
questionnaire had been introduced by Peroni et al. and
used in previous epidemiological studies [12]. The WQ
contained the three core ISAAC (International Study on
Asthma and Allergy in Children) modules asking about
the diagnosis of atopic dermatitis, allergic rhinitis,
wheezing, and asthma [11] according to a precise diag-
nosis performed by a pediatrician or general practitioner
or hospital doctor. In particular, the items of the ques-
tionnaire addressed the presence (either long-lasting or
recent, i.e. in the last 12 months) of signs and symptoms
of AD (eczema), rhinitis and asthma.
The questionnaire was delivered directly and person-
ally to the parents to be filled in at home and returned
when completed in a sealed envelope. After written and
signed consent by the parents had been received, we
submitted all the study subjects to SPT and APT using
the most common aeroallergens in our geographic area:
pollens (grasses, Parietaria, cypress, Compositae), house
dust mites, cat epithelium, and Alternaria tenuis.
For SPT we used diagnostic material from Stallergenes
(Antony, France), testing as negative control glicerosalin
solution and as positive control histamine (10 mg/ml),
according to the guidelines of the European Academy of
Allergy and Clinical Immunology (EAACI) [14]; the re-
actions were considered positive in the presence of awheal diameter of at least 3 mm and larger than the
negative control.
For APT, we used the diagnostic material from Che-
motecnique (Wellinge, Sweden). The substance to be
tested was applied onto intact skin of the lower back
and held firmly in position using an adhesive patch test
made up of an aluminum Finn chamber 8 mm in diam-
eter, with an area of 50 mm2 and a volume of about
20 μl.
The application period was 48 h. The test was read no
less than 30 min after removal to avoid margin effect.
Results were interpreted according to the American
Academy of Dermatology for APT, with a scale ranging
from 1+ (weak reaction) to 3+ (strong reaction) [15].
Only reactions of 2+ and 3+ were considered positive
for the purpose of the study. Table 1 shows the list and
position of the allergens tested. The Finn Chamber with
Petrolatum was used as the control test. We made sure
that the families had been informed that they should
avoid giving antihistamines to the children during the
three-day period preceding the application of APT. We
also advised them not to apply creams/ointments con-
taining corticosteroids in the week before the test.
Statistical analysis
Data are presented as percentages and as mean ± SD for
qualitative and quantitative variables, respectively. Statis-
tical analysis was performed using χ2 test for categorical
variables. Contingency tables were used to analyze the
association between the categorical variables and the
tests used in the study (APT and SPT). Statistical signifi-
cance was assumed for p < 0.05. The positive and nega-
tive predictive values were calculated as appropriate and
the limits of the 95 % confidential interval displayed
(CI95%).
Results
Of the 459 questionnaires delivered to the families, 456
(244 males, 212 females) were returned. Table 2 shows
the clinical pictures according to age and gender ob-
tained from the answers to the questionnaire.
Table 2 Distribution of the studied population according to the different clinical expressions of allergy as assessed by
questionnaires
Atopic dermatitis Rhinitis Asthma/wheezing
subjects N° 66 109 66
males:females 43:23 66:43 36:30
age range (years) 7.8 – 13.2 7.8 – 13.2 8.2 – 13.3
mean age ± DS 10.9 ± 1.5 10.7 ± 1.6 11.3 ± 1.3
Ever Last 12 months Ever Last 12 months Ever Last 12 months
subjects N° (%) 65 1 104 5 66 0
males: females 42:23 1:0 63:41 3:2 36:30 —
age range (years) 7.8 – 13.2 — 7.8 – 13.2 12.2 – 13.2 8.2 – 13.3 —
mean age ± DS 10.9 ± 1.5 — 10.7 ± 1.6 12.5 ± 0.4 11.3 ± 1.3 —
Fuiano et al. Clinical and Molecular Allergy  (2015) 13:2 Page 3 of 5Of the 456 questionnaires returned, 279 (61.2 %) were
negative for any sign or symptom, while 177 (38.8 %)
were positive for symptoms of AD, rhinitis, or asthma/
wheezing. In particular, 129 (28.3 %) were positive for
only one kind of symptoms and 48 (10.5 %) were posi-
tive for more than one kind of symptoms. Overall, there
were 66 questionnaires positive for AD, 109 for rhinitis,
and 66 for asthma/wheezing. Most signs and symptoms
were long-lasting, while only in 6 subjects the onset of
signs and symptoms was in the last 12 months. In the
279 subjects with negative history, 29 (10.4 %) had a
positive SPT and 26 (9.3 %) had a positive APT. In the
177 subjects with positive history, 49 (27.7 %) had a
positive SPT and 31 (17.5 %) had a positive APT.
In the overall study population of 456 subjects, 78
(17.1 %) had a positive SPT and 57 (12.5 %) had a posi-
tive APT. In particular, 61 subjects (13.4 %) were posi-
tive only to SPT and 40 (8.8 %) were positive only to
APT. The rate of positive test was significantly higher in
males than in females both for SPT (22.1 % vs. 11.3 %, pFigure 1 Rate of positive APT and positive SPT according to the histo= 0.002) and APT (15.6 % vs. 9 %, p = 0.033). No positive
result to control tests occurred, both for glicerosalin so-
lution in SPT and for petrolatum control for APT.
Figure 1 shows the results to APT and SPT according
to the different clinical history. Significant differences
were found for a higher rate of positive SPT concerning
subjects with a history of asthma/wheezing ever, with a
history of rhinitis ever, and with a negative history of
AD ever. Table 3 shows the results to the single allergens
tested. The allergen most frequently positive was the
house dust mite, with 41 positive results to SPT and 55
to APT.
Discussion
Epidemiology is a powerful tool in investigating the im-
portance of allergic diseases. Studies conducted lately
have shown a continuous increase in the prevalence of
allergy. In particular, the important ISAAC study focused
on three major allergic diseases (asthma, rhinitis, and
AD) and included a large number of countriesry data.
Table 3 Results to APT and SPT for the single allergens
tested
Positive SPT Positive APT
Alternaria tenuis 8 0
Cypress pollen 29 0
Compositae pollen 4 2
Dermatophagoides 41 55
Cat epithelium 9 0
Grass pollen 28 3
Parietaria pollen 4 1
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was completed a mean of 7 years after Phase One, an in-
creased prevalence for at least one disorder. Increases
were twice as common as decreases, and were more
common in the 6–7 year age-group than in the 13–14
year age-group. For both age-groups, the majority of
participating centres showed increases in all three disor-
ders. All epidemiological surveys on allergy are based on
questionnaires addressing the common symptoms of al-
lergy and, quite often, on diagnostic tests such as SPT or
specific IgE measurement. However, it is known since
the classification by Coombs and Gell of the immuno-
pathologic mechanisms [17] that the IgE-mediated
mechanism drives a great part of allergies, but also other
mechanisms are important. This was finally acknowl-
edged in the Report of the Nomenclature Review
Committee of the World Allergy Organization by
Johansson et al. [18]. Among the different mechanisms,
the T-cell-mediated one has long been recognized as de-
cisive in AD, this attributing to the APT a significant
diagnostic role, initially shown for sensitization to foods
[19] but later also for sensitization to inhalant allergens
and particularly to house dust mites [20,21]. The recent
research further expanded the clinical importance of
APT, based on the demonstration that this test is posi-
tive also in patients with respiratory allergy [3-5,22]. The
fact that the APT may be the only positive test in pa-
tients with respiratory allergy underlines the importance
of including this test in the diagnostic work-up of al-
lergy. Otherwise, patients with negative results to SPT
or in vitro IgE tests may be erroneously classified as
nonallergic. Adding the APT allows us to achieve a cor-
rect diagnosis [23]. As far as the use of diagnostic tests
in epidemiologic surveys is concerned, no studies using
the APT are available other than those performed in
populations of patients already known as allergic [9,10].
The present study shows that a positive APT is quite
common in an unselected pediatric population, formed
by all subjects attending Primary School and Junior Sec-
ondary School in a small Southern Italian town. Among
the 456 subjects included in the survey, 17.1 % had apositive SPT and 12.5 % had a positive APT. The preva-
lence of positive SPT must be compared with epidemio-
logical studies in the latest decade. In the European
Community Respiratory Health Survey on adult subjects
there was a wide variation in the prevalence of
sensitization in the different countries, with a median
between centres of 21.7 % for dust mite, 16.9 % for grass
pollen, and 8.8 % for cat [24]. The recent study by
Blomme et al. found in an unselected population in
Ghent (Belgium), of age ranging from 3 to 86 years, an
overall prevalence of positive SPT to common aeroaller-
gens of 40.3 %, with a clinical diagnosis of allergic rhin-
itis in 30.9 % of cases. The peaks of prevalence were
observed in the third and fourth decades of life, but also
in pediatric age the prevalence of positive SPT was
higher than 25 % [25]. The 17.1 % positive SPT rate we
observed is lower, but the environment where our survey
was performed may explain this difference. San Marco
in Lamis is a small town of 12,000 inhabitants in a rural
area, while Ghent, with around 245,000 inhabitants is
Belgium's second largest municipality. A rural environ-
ment, like that of San Marco in Lamis, was found to be
less favorable than urban areas for developing allergic
diseases [26]. Analyzing only the subjects with symp-
toms, the rate of positive SPT was around 28 %. This
value is comparable with data from previous studies on
unselected populations of children [27,28], but is obvi-
ously much lower than observed in patients referring to
specialists for allergological evaluation.
The findings on positive APT (9.3 %) in subjects with
negative history and 17.5 % in subjects with positive his-
tory cannot be compared with previous epidemiological
data, because there are no studies that limited the inves-
tigation to APT results to only inhalant allergens. How-
ever, we can confirm the observations from clinical
studies [5,9,21] that APT may give positive results in
concordance with SPT but may also be the only positive
test (3.7 % and 8.8 % in the present study, respectively).
The major role played by the house dust mite was also
confirmed, with positive results accounting for 33.3 % of
the overall positivity to SPT and to 91.1 % of the overall
positivity to APT. Instead, in our study sensitization to
pollens was almost exclusively IgE-mediated.Conclusion
In this survey on an unselected population of children
we observed a prevalence of positive results to APT not
so distant from the positive results to SPT, especially
concerning dust mites, and in 8.8 % of subjects the APT
was the only positive test. This would suggest that by
adding the APT in future epidemiological studies on al-
lergy, would mean avoiding the not negligible portion of
patients with T-cell-mediated allergy being overlooked.
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